REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanpar Pharmachem Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanpar Pharmachem Private Limited Profile Updated: May 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Shanpar Pharmachem Private Limited is an enterprise in India, with the main office in Chennai. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on August 17, 2011. In its most recent financial highlights, the company reported a net sales revenue increase of 15.08% in 2025. There was a total growth of 36.22% in Shanpar Pharmachem Private Limited’s total assets over the same period. The enterprise’s net profit margin decreased by 0.01% in 2025.

Legal Address
7, South Gangai Amman Koil 1St Street Choolaimedu
Chennai; Tamil Nadu; Postal Code: 600094

Contact Details: Purchase the Shanpar Pharmachem Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Shanpar Pharmachem Private Limited report to view the information.
Financial Auditors:
Purchase the Shanpar Pharmachem Private Limited report to view the information.
Incorporation Date:
August 17, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Shanpar Pharmachem Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
15.08%
Total Operating Revenue
15.18%
Operating Profit
13.91%
EBITDA
12.21%
Net Profit/Loss for the Period
14.03%
Total Assets
36.22%
Total Equity
25%
Operating Profit Margin
-0.03%
Net Profit Margin
-0.01%
Return on Equity (ROE)
-1.92%
Quick Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?